RxDoctor Payments Data

Logan Pritchard, DO

Family Medicine · Hastings, NENPI 1255539730

Payments from drug & device makers

$1,194in general payments, 2019–2025

Across 72 payments — averaging $16.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$632
  • Novo Nordisk$179
  • Pfizer$154
  • Amgen$65
  • Lilly USA, LLC$28
  • Astellas Pharma US Inc$19
  • plus $117 from 8 others

What the payments were for

  • Food & beverage$1,194100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,194 in reported general payments places this provider in the 60th percentile of 981 family medicine providers in Nebraska.

See all family medicine providers in Nebraska

Medicare billing

Part B allowed, 2024
$164,448
Medicare patients
335
Services billed
5,156

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban170$99,245
JardianceEmpagliflozin39$38,981
TrulicityDulaglutide21$34,927
OzempicSemaglutide36$33,465
Trelegy ElliptaFluticasone/Umeclidin/Vilanter39$30,601
FarxigaDapagliflozin Propanediol23$20,245
Breztri AerosphereBudesonide/Glycopyr/Formoterol20$17,869
Breo ElliptaFluticasone/Vilanterol27$15,032
Soliqua 100-33Insulin Glargine/Lixisenatide14$11,835
XareltoRivaroxaban16$10,925
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog11$10,491
Aimovig AutoinjectorErenumab-Aooe12$8,869
SymbicortBudesonide/Formoterol Fumarate22$8,241
Repatha SureclickEvolocumab13$7,561
JanumetSitagliptin Phos/Metformin Hcl13$6,823

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Paxlovid$154$100,674181 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$14$46,35565 claims
Boehringer IngelheimJardiance$18$38,98139 claims
Lilly USA, LLCTrulicity$28$34,92721 claims
Novo NordiskOzempic$179$33,46536 claims
Johnson & JohnsonXarelto, Invokana$16$17,11827 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$14$11,83514 claims
Astellas Pharma US IncMyrbetriq$19$4,76311 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 981 family medicine providers in Nebraska.

Other family medicine in Hastings

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →